CXCR1 and neoplasm: The CXCR1/CXCR2 signaling nexus directly influences the sensitivity of tumor cells to chemotherapies by altering pathways associated with apoptosis and multidrug resistance [15, 16], resulting in a poor prognosis in human cancer studies [17, 18].